| Trident Lifeline Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543616 |
NSE Symbol : - |
P/E(TTM) : 17.98 |
|
ISIN Demat : INE0MKA01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 14.07 |
|
Book Value(₹) : 76.83 |
Market Cap(₹Cr) : 301.90 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 23.67 | 27.44 | 18.82 | 20.85 | 16.51 | 15.66 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 23.67 | 27.44 | 18.82 | 20.85 | 16.51 | 15.66 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.89 | 1.11 | 0.54 | 1.61 | 0.54 | 0.52 |
| Total Income | 24.56 | 28.55 | 19.35 | 22.46 | 17.05 | 16.18 |
| Total Expenditure | 17.39 | 21.06 | 13.89 | 15.27 | 12.37 | 11.24 |
| PBIDT | 7.17 | 7.49 | 5.46 | 7.18 | 4.68 | 4.94 |
| Interest | 0.54 | 0.42 | 0.33 | 0.46 | 0.35 | 0.27 |
| PBDT | 6.64 | 7.07 | 5.14 | 6.73 | 4.33 | 4.67 |
| Depreciation | 0.71 | 0.59 | 0.51 | 0.71 | 0.38 | 0.16 |
| Tax | 1.84 | 1.54 | 1.15 | 1.06 | 0.92 | 1.12 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.07 | 0.00 | 0.00 | 0.60 | 0.00 | 0.00 |
| Reported Profit After Tax | 4.01 | 4.94 | 3.48 | 4.35 | 3.03 | 3.39 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 4.01 | 4.94 | 3.48 | 4.35 | 3.03 | 3.39 |
| EPS (Unit Curr.) | 3.47 | 4.26 | 3.02 | 3.79 | 2.63 | 2.95 |
| EPS (Adj) (Unit Curr.) | 3.47 | 4.26 | 3.02 | 3.79 | 2.63 | 2.95 |
| Calculated EPS (Unit Curr.) | 3.36 | 4.26 | 3.02 | 3.79 | 2.63 | 2.95 |
| Calculated EPS (Adj) (Unit Curr.) | 3.36 | 4.26 | 3.02 | 3.79 | 2.63 | 2.95 |
| Calculated EPS (Ann.) (Unit Curr.) | 13.46 | 17.05 | 12.09 | 15.15 | 10.53 | 11.80 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 13.46 | 17.05 | 12.09 | 15.15 | 10.53 | 11.80 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 11.93 | 11.59 | 11.50 | 11.50 | 11.50 | 11.50 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 30.29 | 27.30 | 29.01 | 34.44 | 28.35 | 31.55 |
| PBDTM(%) | 28.05 | 25.77 | 27.31 | 32.28 | 26.23 | 29.82 |
| PATM(%) | 16.94 | 18.00 | 18.49 | 20.86 | 18.35 | 21.65 |
